Literature DB >> 32594042

Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease.

Rachita K Sumbria1.   

Abstract

Entities:  

Year:  2020        PMID: 32594042     DOI: 10.4103/1673-5374.284994

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


× No keyword cloud information.
  4 in total

Review 1.  Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease.

Authors:  Dapinder Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vishnu Nayak Badavath; Syed Shams Ul Hassan; Mohammad Mehedi Hasan; Saurabh Bhatia; Ahmed Al-Harassi; Haroon Khan; Simona Bungau
Journal:  Metab Brain Dis       Date:  2021-08-26       Impact factor: 3.584

2.  Therapeutic potential of dental pulp stem cell transplantation in a rat model of Alzheimer's disease.

Authors:  Xue-Mei Zhang; Yuan-Jiao Ouyang; Bing-Qian Yu; Wei Li; Mei-Yu Yu; Jin-Yue Li; Zhuo-Min Jiao; Dan Yang; Na Li; Ying Shi; Yun-Yun Xu; Zhi-Jun He; Duo Wang; Hui Yue; Jin Fu
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

3.  Preventive electroacupuncture reduces cognitive deficits in a rat model of D-galactose-induced aging.

Authors:  Chao-Chao Yu; Chuan He; Yan-Jun Du; Shan Gao; Yuan-Fang Lin; Shu-Qin Wang; Li Wang; Jia Wang; Xue-Song Wang; Tao Jiang; Li-Hong Kong
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

4.  Transferrin receptor 1 plays an important role in muscle development and denervation-induced muscular atrophy.

Authors:  Ying Li; Juan-Xian Cheng; Hai-Hong Yang; Li-Ping Chen; Feng-Jiao Liu; Yan Wu; Ming Fan; Hai-Tao Wu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.